The insulin-like growth factor (IGF) signaling pathway has been associated with both initiation and progression of breast cancer.16 IGF1 and IGF2 signal through tyrosine kinase receptors, insulin receptors (IR) and IGF receptors 1 and 2 (IGF1R and IGF2R). This evidence concerns the gene IGF1R and breast carcinoma.